Medical technology startup Epsilon Imaging is preparing to launch its second product in late April according to a report from Concentrate Media. The cardio oncology application will allow doctors to see if cancer medications are negatively impacting a patient’s heart.

The company, which has a staff of 12, recently hired a director of sales and an additional software developer. According to the Concentrate report, Epsilon will look to begin fundraising shortly for a Series B round worth somewhere in the neighborhood of $5 million.

Epsilon’s first product, Stress Echo, is installed at 12 hospitals across the country. The ultrasound technology helps doctors measure the strength of a patient’s heart muscles.

• Read the full story from Concentrate.

Ben Freed covers business for AnnArbor.com. You can sign up here to receive Business Review updates every week. Reach out to Ben at 734-623-2528 or email him at benfreed@annarbor.com. Follow him on twitter @BFreedinA2